FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Home Diagnostics, Inc. (Nasdaq:HDIX), leading manufacturer and marketer of diabetes testing supplies, today announced that its Board of Directors authorized the company to repurchase up to $5 million of its common stock to be funded with available cash. This program follows two stock repurchase programs of $5 million each that were completed in 2007 and 2008.
